Sarah Cannon And Syapse Launch Precision Oncology Clinical Service To Expand Targeted Treatment Options For Patients

NASHVILLE, Tenn. & PALO ALTO, Calif.--(BUSINESS WIRE)--Sarah Cannon, the global cancer enterprise of Hospital Corporation of America (HCA), which offers cutting-edge clinical research alongside integrated cancer services, and Syapse, the leading provider of precision medicine software, announced plans today to launch a precision oncology clinical service collaboration. The software-based service is designed to support Sarah Cannon’s efforts to make tumor genome profiling a key component of the care continuum for the more than 100,000 newly diagnosed cancer patients seen annually across its network of cancer centers throughout the United States and United Kingdom.

Help employers find you! Check out all the jobs and post your resume.

Back to news